Daniel E. Geffken's Net Worth
-$3.93 Thousand
Who is Daniel E. Geffken?
Daniel E. Geffken does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cyberkinetics Neurotechnology Systems, Inc., CERO THERAPEUTICS HOLDINGS, INC., WINDTREE THERAPEUTICS INC /DE/, Marina Biotech, Inc., Locust Walk Acquisition Corp., Eloxx Pharmaceuticals, Inc., ProMIS Neurosciences Inc., and CalciMedica, Inc..
SEC CIK
Daniel E. Geffken's CIK is 0001314756
Past Insider Trading and Trends
2021 was Daniel E. Geffken's most active year for acquiring shares with 4 total transactions. Daniel E. Geffken's most active month to acquire stocks was the month of May. 2021 saw Daniel E. Geffken paying a total of $36,000.00 for 180,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cyberkinetics Neurotechnology Systems, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CERO THERAPEUTICS HOLDINGS, INC. (PBAX) No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
WINDTREE THERAPEUTICS INC /DE/ (WINT) Snapshot price: $2.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,431.69% | 2.03K |
—
|
—
| 2.17K |
Aug 23
| |||
Form 4
| +241.66% | 5K |
—
|
—
| 7.07K |
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
∞
| 2.07K |
$7.25 | $15,000.25 | 2.07K |
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Marina Biotech, Inc. (ATRX) No price found
Interim CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Locust Walk Acquisition Corp. (EFTR) Snapshot price: $0.0783
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||